Randomized Placebo-Controlled Trial to Evaluate Effects of Eplerenone on Myocardial Perfusion and Function Among Persons With Human Immunodeficiency Virus (HIV)—Results From the MIRACLE HIV Study.

MLA

Srinivasa, Suman, et al. “Randomized Placebo-Controlled Trial to Evaluate Effects of Eplerenone on Myocardial Perfusion and Function Among Persons With Human Immunodeficiency Virus (HIV)—Results From the MIRACLE HIV Study.” Clinical Infectious Diseases, vol. 77, no. 8, Oct. 2023, pp. 1166–75. EBSCOhost, https://doi.org/10.1093/cid/ciad310.

APA

Srinivasa, S., Walpert, A. R., Thomas, T. S., Huck, D. M., Jerosch-Herold, M., Islam, S., Lu, M. T., Burdo, T. H., deFilippi, C. R., Dunderdale, C. N., Feldpausch, M., Iyengar, S., Shen, G., Baak, S., Torriani, M., Robbins, G. K., Lee, H., Kwong, R., DiCarli, M., & Adler, G. K. (2023). Randomized Placebo-Controlled Trial to Evaluate Effects of Eplerenone on Myocardial Perfusion and Function Among Persons With Human Immunodeficiency Virus (HIV)—Results From the MIRACLE HIV Study. Clinical Infectious Diseases, 77(8), 1166–1175. https://doi.org/10.1093/cid/ciad310

Chicago

Srinivasa, Suman, Allie R Walpert, Teressa S Thomas, Daniel M Huck, Michael Jerosch-Herold, Sabeeh Islam, Michael T Lu, et al. 2023. “Randomized Placebo-Controlled Trial to Evaluate Effects of Eplerenone on Myocardial Perfusion and Function Among Persons With Human Immunodeficiency Virus (HIV)—Results From the MIRACLE HIV Study.” Clinical Infectious Diseases 77 (8): 1166–75. doi:10.1093/cid/ciad310.